Jan 10, 2024, 11:54
ESMO Guideline: Oncogene-Addicted mNSCLC – The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on X/Twitter:
“ESMO Guideline: Oncogene-Addicted mNSCLC. Developed due 2 advances in biomarker identification and targeted therapies; updated recommendations and treatment algorithms on new and clinically relevant biomarker identification, targeting and advanced disease management.”
View additional information.
Source: The European Society for Medical Oncology (ESMO)/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48